Mr Mark Potts was appointed to the Board as a Non-Executive Director in June 2017. Mr Potts is Chair of the Remuneration Committee (from 20 February 2020), and a member of the Audit and Risk Committee and the Nomination Committee.
Mr Potts is a leading global technology and business executive. He has founded multiple venture backed technology
and technology services companies in Australia, the UK and the US. Most
recently, Mr Potts was a HP Fellow and Chief Technology Officer/Vice President of Corporate Strategy at Hewlett-Packard Enterprise in the US, leading their efforts in both M&A, technology investment and capital strategy.
Mr Potts is and has been a non-executive director and chairman at several
ASX-listed technology companies that are involved in disruption within both financial services/ superannuation, security/surveillance automation and government service digitisation. He has deep expertise in technology lead innovation leveraging Robotic Process Automation, AI/machine learning, and
Blockchain technology, as well as public policy change and privatisation of government soft assets into public and private partnership.
Mr Potts has worked across multiple jurisdictions including the UK, Europe, US and Asia Pacific.
Mr Potts is also a non-executive director at Linear Clinical Research Limited, a purpose built state-of-the-art, clinical trials facility and a focal point for Australian clinical and medical research.
Mr Potts is a Member of the Australian Institute of Company Directors.
Current listed directorships
- Non-Executive Chairman of iCetana Ltd (appointed 2018)
Other current directorships/ appointments
- Non-Executive Director of Linear Clinical Research Limited (appointed 2019)
- Non-Executive Director of Land Services WA